Last updated: September 23, 2021
Sponsor: Francisco Espinoza
Overall Status: Active - Not Recruiting
Phase
1
Condition
Osteoarthritis
Treatment
N/AClinical Study ID
NCT05060107
C4C060921
Ages 30-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Symptomatic knee OA with VAS >50mm
- Knee OA Kellgren-Lawrence grade II to III
- Chondromalacia grade I to III
- Stable joint
Exclusion
Exclusion Criteria:
- Bilateral symptomatic knee OA
- Local infection
- Neoplasia
- Joint replacement
- Recent use of local steroids
- BMI > 30
Study Design
Total Participants: 10
Study Start date:
October 05, 2021
Estimated Completion Date:
October 05, 2023